This is a post-market, prospective, interventional, nonblinded, global, multi- center, randomized, dual-arm clinical study. The primary objective of this study is to evaluate sac regression outcomes of the Medtronic Endurant II/IIs Stent Graft System and Gore Excluder/Excluder Conformable AAA Endoprosthesis in standard EVAR subjects. Subjects will be randomized on a 1:1 basis to receive EVAR with either a Medtronic Endurant II/IIs Stent Graft Systems or Gore Excluder / Excluder Conformable AAA Endoprosthesis. Data will be collected pre- and post-procedure at discharge, at 30 days, and once a year until the 5-year follow-up is completed.~Product Names:~Medtronic Endurant II/IIs Stent Graft System~Gore Excluder and/or Gore Excluder Conformable AAA Endoprosthesis Imaging will be collected for all follow-up time points and be evaluated by a core lab for the key primary and secondary objectives.
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects will be randomized and imaging will be collected at all follow-up time points to assess the primary endpoint.